Urine Test Could Help Assess Aspects of Cystic Fibrosis
New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.
New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.
IGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Over time, the American Medical Association has established specific current procedural terminology codes to be used in reporting the results of testing by means of such multiplex molecular pathology panels.
The panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read MoreThe study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MoreThe BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.
Read MoreThe test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.
Read MoreNew module expands molecular testing capabilities, increases productivity and flexibility for the laboratory.
Read MoreliTechGroup Molecular Diagnostics has launched a multiplex assay, the respiratory bacterial Elite MGB panel, for the diagnosis of bacterial respiratory infections.
Read MoreRunning on the company’s Panther Fusion system, the new assay detects adenovirus, human metapneumovirus, and rhinovirus.
Read MoreHologic has received premarket notification (510(k)) clearance from FDA for its Panther Fusion Flu A/B/RSV assay running on the company’s new Panther Fusion system.
Read MoreARUP Laboratories and IDbyDNA have announced the launch of Explify Respiratory, a next-generation sequencing test for respiratory infections.
Read MoreThe ePlex diagnostic platform integrates nucleic acid extraction, amplification, and detection into a fully automated, sample-to-answer system.
Read MoreProtecting sample stability ensures the utility of the latest generation of TB tests.
Read MoreThe US National Tuberculosis Controllers Association and the Association of Public Health Laboratories have recommended the use of the Xpert MTB/RIF test to support decisionmaking on using airborne infection isolation in healthcare settings.
Read MoreThe landmark NIH study represents a major advance in tuberculosis research.
Read MoreThe NxTag respiratory panel from Luminex enables laboratories to detect 20 respiratory pathogens simultaneously in a single closed-tube system.
Read MoreThe closed-tube, scalable, 96-well based system from Luminex seeks to meet clinical demand for respiratory disease testing.
Read More